<?xml version="1.0" encoding="UTF-8"?>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95367586</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="transcription_factor" sem="G#protein_family_or_group"><w c="NN">Transcription</w> <w c="NNS">factors</w></cons> <w c="IN">as</w> <w c="NNS">targets</w> <w c="IN">for</w> <w c="JJ">oxidative</w> <w c="NN">signalling</w> <w c="IN">during</w> <cons lex="lymphocyte_activation" sem="G#other_name"><w c="NN">lymphocyte</w> <w c="NN">activation</w></cons><w c=".">.</w></sentence>
</title>
<abstract>
<sentence><w c="PRP">We</w> <w c="RB">previously</w> <w c="VBP">have</w> <w c="VBN">demonstrated</w> <w c="DT">a</w> <w c="NN">requirement</w> <w c="IN">for</w> <w c="JJ">oxidative</w> <w c="NNS">events</w> <w c="IN">during</w> <w c="NN">cell</w> <w c="NN">cycle</w> <w c="NN">entry</w> <w c="IN">in</w> <cons lex="T_lymphocyte" sem="G#cell_type"><w c="NN">T</w> <w c="NNS">lymphocytes</w></cons> <w c="CC">and</w> <w c="VBP">have</w> <w c="VBN">hypothesised</w> <w c="IN">that</w> <cons lex="reactive_oxygen_specie" sem="G#inorganic"><w c="JJ">reactive</w> <w c="NN">oxygen</w> <w c="NNS">species</w></cons> <w c="MD">may</w> <w c="VB">act</w> <w c="IN">as</w> <cons lex="intracellular_signalling_agents" sem="G#other_name"><w c="JJ">intracellular</w> <w c="VBG">signalling</w> <w c="NNS">agents</w></cons> <w c="IN">during</w> <cons lex="lymphocyte_activationp" sem="G#other_name"><w c="NN">lymphocyte</w> <w c="NN">activation</w></cons><w c=".">.</w></sentence>
<sentence><w c="IN">In</w> <w c="DT">the</w> <w c="JJ">current</w> <w c="NN">study</w><w c=",">,</w> <cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">cysteamine</w></cons><w c=",">,</w> <w c="DT">an</w> <cons lex="aminothiol_compound" sem="G#other_organic_compound"><w c="NN">aminothiol</w> <w c="NN">compound</w></cons> <w c="IN">with</w> <cons lex="antioxidant_activity" sem="G#other_name"><w c="JJ">antioxidant</w> <w c="NN">activity</w></cons><w c=",">,</w> <w c="VBZ">has</w> <w c="VBN">been</w> <w c="VBN">used</w> <w c="TO">to</w> <w c="RB">further</w> <w c="VB">investigate</w> <w c="DT">the</w> <w c="NN">role</w> <w c="IN">of</w> <cons lex="oxidative_signalling" sem="G#other_name"><w c="JJ">oxidative</w> <w c="NN">signalling</w></cons> <w c="IN">during</w> <cons lex="lymphocyte_activation" sem="G#other_name"><w c="NN">lymphocyte</w> <w c="NN">activation</w></cons><w c=".">.</w></sentence>
<sentence><w c="NN">Treatment</w> <w c="IN">of</w> <w c="JJ">normal</w> <cons lex="human_peripheral_blood_lymphocyte" sem="G#cell_type"><w c="JJ">human</w> <w c="JJ">peripheral</w> <w c="NN">blood</w> <w c="NNS">lymphocytes</w></cons> <w c="IN">with</w> <cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">cysteamine</w></cons> <w c="FW">in</w> <w c="FW">vitro</w> <w c="VBD">was</w> <w c="VBN">found</w> <w c="TO">to</w> <w c="VB">inhibit</w> <cons lex="proliferation" sem="G#other_name"><w c="NN">proliferation</w></cons> <w c="IN">in</w> <w c="DT">a</w> <cons lex="dose-dependent_manner" sem="G#other_name"><w c="JJ">dose-dependent</w> <w c="NN">manner</w></cons><w c=",">,</w> <w c="IN">with</w> <w c="RB">essentially</w> <w c="JJ">complete</w> <w c="NN">inhibition</w> <w c="VBG">occurring</w> <w c="IN">at</w> <w c="DT">a</w> <w c="NN">dose</w> <w c="IN">of</w> <w c="CD">400</w> <w c="NN">microM</w><w c=".">.</w></sentence>
<sentence><w c="DT">This</w> <w c="JJ">inhibitory</w> <w c="NN">effect</w> <w c="VBD">was</w> <w c="JJ">limited</w> <w c="TO">to</w> <w c="DT">the</w> <w c="JJ">first</w> <w c="CD">2</w> <w c="NN">h</w> <w c="IN">after</w> <cons lex="mitogenic_activation" sem="G#other_name"><w c="JJ">mitogenic</w> <w c="NN">activation</w></cons><w c=",">,</w> <w c="VBG">localizing</w> <w c="DT">the</w> <w c="NN">time-frame</w> <w c="IN">of</w> <w c="NN">action</w> <w c="IN">of</w> <cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">cysteamine</w></cons> <w c="TO">to</w> <w c="IN">within</w> <w c="DT">the</w> <cons lex="commitment_period" sem="G#other_name"><w c="NN">commitment</w> <w c="NN">period</w></cons><w c=".">.</w></sentence>
<sentence><w c="PRP">It</w> <w c="RB">therefore</w> <w c="VBD">was</w> <w c="IN">of</w> <w c="NN">interest</w> <w c="TO">to</w> <w c="VB">establish</w> <w c="WDT">which</w><w c=",">,</w> <w c="IN">if</w> <w c="DT">any</w><w c=",">,</w> <w c="NN">commitment</w> <w c="NNS">events</w> <w c="VBD">were</w> <w c="VBN">affected</w> <w c="IN">by</w> <cons lex="oxidative_signalling" sem="G#other_name"><w c="JJ">oxidative</w> <w c="NN">signalling</w></cons> <w c="IN">during</w> <cons lex="cell_cycle_entry" sem="G#other_name"><w c="NN">cell</w> <w c="NN">cycle</w> <w c="NN">entry</w></cons><w c=".">.</w></sentence>
<sentence><w c="VBG">Taking</w> <w c="DT">the</w> <cons lex="IL-2_gene" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule"><w c="NN">IL-2</w></cons> <w c="NN">gene</w></cons> <w c="IN">as</w> <w c="DT">a</w> <w c="NN">candidate</w><w c=",">,</w> <w c="PRP">we</w> <w c="VBD">examined</w> <w c="DT">the</w> <w c="NN">effect</w> <w c="IN">of</w> <cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">cysteamine</w></cons> <w c="NN">treatment</w> <w c="IN">on</w> <cons lex="early_gene_expression" sem="G#other_name"><cons lex="early_gene" sem="G#DNA_family_or_group"><w c="JJ">early</w> <w c="NN">gene</w></cons> <w c="NN">expression</w></cons> <w c="IN">during</w> <cons lex="lymphocyte_activation" sem="G#other_name"><w c="NN">lymphocyte</w> <w c="NN">activation</w></cons><w c=",">,</w> <w c="CC">and</w> <w c="IN">on</w> <w c="DT">the</w> <w c="NN">activity</w> <w c="IN">of</w> <cons lex="transcription_factor" sem="G#protein_family_or_group"><w c="NN">transcription</w> <w c="NNS">factors</w></cons> <cons lex="AP-1" sem="G#protein_molecule"><w c="NN">AP-1</w></cons><w c=",">,</w> <cons lex="NF-kappa_B" sem="G#protein_molecule"><w c="NN">NF-kappa</w> <w c="NN">B</w></cons><w c=",">,</w> <cons lex="NF-AT" sem="G#protein_molecule"><w c="NN">NF-AT</w></cons> <w c="CC">and</w> <cons lex="Oct1" sem="G#protein_molecule"><w c="NN">Oct1</w></cons><w c=",">,</w> <w c="WP$">whose</w> <w c="NNS">functions</w> <w c="VBP">are</w> <w c="VBN">required</w> <w c="IN">for</w> <w c="NN">expression</w> <w c="IN">of</w> <w c="DT">the</w> <cons lex="IL-2" sem="G#protein_molecule"><w c="NN">IL-2</w></cons> <w c="NN">mRNA</w><w c=".">.</w></sentence>
<sentence><cons lex="c_treatment" sem="G#other_name"><cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">Cysteamine</w></cons> <w c="NN">treatment</w></cons> <w c="VBD">inhibited</w> <w c="CC">both</w> <w c="NN">expression</w> <w c="IN">of</w> <w c="DT">the</w> <cons lex="IL-2_mRNA" sem="G#RNA_molecule"><cons lex="IL-2" sem="G#protein_molecule"><w c="NN">IL-2</w></cons> <w c="NN">mRNA</w></cons> <w c="CC">and</w> <w c="NN">secretion</w> <w c="IN">of</w> <cons lex="IL-2" sem="G#protein_molecule"><w c="NN">IL-2</w></cons> <w c="IN">into</w> <w c="DT">the</w> <cons lex="culture_medium" sem="G#other_organic_compound"><w c="NN">culture</w> <w c="NN">medium</w></cons><w c=".">.</w></sentence>
<sentence><w c="DT">The</w> <w c="JJ">inhibitory</w> <w c="NN">effect</w> <w c="IN">of</w> <cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">cysteamine</w></cons> <w c="MD">may</w> <w c="VB">be</w> <w c="VBN">mediated</w> <w c="IN">at</w> <w c="JJS">least</w> <w c="IN">in</w> <w c="NN">part</w> <w c="IN">by</w> <w c="DT">an</w> <w c="NN">effect</w> <w c="IN">on</w> <cons lex="transcription_factor_function" sem="G#other_name"><cons lex="transcription_factor" sem="G#protein_family_or_group"><w c="NN">transcription</w> <w c="NN">factor</w></cons> <w c="NN">function</w></cons><w c=",">,</w> <w c="IN">as</w> <w c="DT">the</w> <w c="NN">DNA</w> <cons lex="binding_activity" sem="G#other_name"><w c="NN">binding</w> <w c="NNS">activities</w></cons> <w c="IN">of</w> <cons lex="AP-1" sem="G#protein_molecule"><w c="NN">AP-1</w></cons> <w c="CC">and</w> <cons lex="NF-kappa_B" sem="G#protein_molecule"><w c="NN">NF-kappa</w> <w c="NN">B</w></cons> <w c="VBN">extracted</w> <w c="IN">from</w> <cons lex="mitogen-stimulated_cell" sem="G#cell_type"><w c="JJ">mitogen-stimulated</w> <w c="NNS">cells</w></cons> <w c="VBD">were</w> <w c="RB">significantly</w> <w c="VBN">inhibited</w> <w c="IN">by</w> <cons lex="cysteamine_treatment" sem="G#other_name"><cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">cysteamine</w></cons> <w c="NN">treatment</w></cons><w c=".">.</w></sentence>
<sentence><w c="RB">Interestingly</w><w c=",">,</w> <cons lex="(AND Oct1_DNA_binding_activity NF-AT_DNA_binding_activity)" sem="(AND G#other_name G#other_name)"><cons lex="Oct1*"><w c="NN">Oct1</w></cons> <w c="CC">and</w> <cons lex="NF-AT*"><w c="NN">NF-AT</w></cons> <cons lex="*DNA_binding_activity"><w c="NN">DNA</w> <w c="NN">binding</w> <w c="NN">activity</w></cons></cons> <w c="VBD">were</w> <w c="RB">not</w> <w c="VBN">affected</w> <w c="IN">by</w> <cons lex="cysteamine" sem="G#other_organic_compound"><w c="NN">cysteamine</w></cons> <w c="NN">treatment</w><w c=",">,</w> <w c="VBG">suggesting</w> <w c="IN">that</w> <cons lex="oxidative_signalling_process" sem="G#other_name"><w c="JJ">oxidative</w> <w c="NN">signalling</w> <w c="NNS">processes</w></cons> <w c="VBP">operate</w> <w c="IN">in</w> <w c="DT">a</w> <w c="JJ">selective</w> <w c="NN">manner</w><w c=".">.</w></sentence>
<sentence><w c="DT">The</w> <w c="NN">identification</w> <w c="IN">of</w> <cons lex="regulatory_protein" sem="G#protein_family_or_group"><w c="JJ">regulatory</w> <w c="NNS">proteins</w></cons><w c=",">,</w> <w c="JJ">such</w> <w c="IN">as</w> <cons lex="transcription_factor" sem="G#protein_family_or_group"><w c="NN">transcription</w> <w c="NNS">factors</w></cons><w c=",">,</w> <w c="IN">as</w> <w c="JJ">molecular</w> <w c="NNS">targets</w> <w c="IN">for</w> <cons lex="oxidative_signalling" sem="G#other_name"><w c="JJ">oxidative</w> <w c="NN">signalling</w></cons> <w c="VBZ">provides</w> <w c="JJ">further</w> <w c="NN">evidence</w> <w c="TO">to</w> <w c="VB">implicate</w> <cons lex="oxidative_signalling" sem="G#other_name"><w c="JJ">oxidative</w> <w c="NN">signalling</w></cons> <w c="IN">as</w> <w c="VBG">being</w> <w c="RB">intimately</w> <w c="VBN">involved</w> <w c="IN">in</w> <w c="DT">the</w> <cons lex="G0_to_G1_phase_transition" sem="G#other_name"><w c="NN">G0</w> <w c="TO">to</w> <w c="NN">G1</w> <w c="NN">phase</w> <w c="NN">transition</w></cons> <w c="IN">in</w> <cons lex="T_lymphocyte" sem="G#cell_type"><w c="NN">T</w> <w c="NNS">lymphocytes</w></cons><w c=".">.</w></sentence>
</abstract>
</article>
